Study on NO-donating antihypertensive agents I. Synthesis and antihypertensive activity of C-3 nitrate or furoxan substituted benzopyrans

Journal of China Pharmaceutical University

Volumn 36, Issue 6, 2005, Pages 488-495

  Xu, Xin ^a   Zhang, Yi Hua ^a   Peng, Si Xun ^a   Ji, Hui ^a   Li, Yong Qi ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antihypertensive; Benzopyran; Furoxan; Nitrate; NO donor; Synthesis

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENZOPYRAN DERIVATIVE; NITRATE; NITRIC OXIDE; ORGANIC NITRATE; PINACIDIL; POTASSIUM CHLORIDE; SUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; AORTA PRESSURE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; HYPERTENSION; INHIBITION KINETICS; NONHUMAN; RAT; SMOOTH MUSCLE CONTRACTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

EID: 30544448498     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Maree AD, Cox D. Thrombosis and nitric oxide donor drugs[J]. Thromb Haemost, 2004,91(5):848-850.
2. Sebille S, deTullio P, Boverie S, et al. Recent developments in the chemistry of potassium channel activators: the cromakalim analogs [J]. Curr Med Chem, 2004,11(9):1 213-1 222.
3. Hay L, Schutte PJ, Du Plooy WJ, et al. The role of cromakalim and a nitric oxide synthase blocker in cardiac arrhythmia in the intact baboon model[J]. J Cardiovasc Pharmacol, 2000,35(2):282-286.
4. + in hypertensive rats[J]. Am J Physiol Heart Circ Physiol, 2002,282(5):1 724-1 731.
5. Stilo AD, Visentin S, Cena C, et al. New 1, 4-dihydropyridines conjugated to furoxanyl moiety, endowed with nitric oxide-like and calcium channel antagonist vasodilator activities[J]. J Med Chem, 1998,41(27):5 395-5 401.
6. Zhao SY, Huang WL, Zhang HB. Chinese source. (Acta Pharm Sci), 2002,37(8):621-625.
7. Li RW, Zhang YH, Ji H, Chinese source. (Acta Pharm Sci), 2001,36(11):821-826.
8. Li RW, Zhang YH, Ji H, Chinese source. (Acta Pharm Sci), 2002,37(1):27-32.
9. Feng XC, Ji H, Zhang YH, Chinese source. (J China Pharm Univ), 2004,35(4):357-360.
10. Yan Z, Huang WL, Peng SX, Chinese source. (Acta Pharm Sci), 1997,32(2):97-105.